Publications by authors named "Khaled Hani Aburisheh"
Introduction: Semaglutide, a Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA), is often prescribed for managing type 2 diabetes, particularly in cases unresponsive to other hypoglycemic agents. Despite its popularity, the real-world efficacy and cost-effectiveness of Semaglutide relative to other treatments remain understudied.
Objective: This study aimed to examine the direct medical cost and consequences of adding Semaglutide to the treatment regimen for patients with type 2 diabetes in Saudi Arabia.
Evaluation of carbohydrate counting knowledge among individuals with type 1 diabetes mellitus in Saudi Arabia: a cross-sectional study.
Nahla Mohammed Bawazeer Leena Hamdan Alshehri Nouf Mohammed Alharbi Noha Abdulaziz Alhazmi Alhanouf Fahad Alrubaysh Khaled Hani Aburisheh
BMJ Nutr Prev Health
December 2022
Article Synopsis
- Carbohydrate counting (CC) is a vital nutritional strategy that can enhance glycaemic control in diabetes patients, yet there's limited research on CC knowledge among those with type 1 diabetes (T1DM) in Saudi Arabia.
- A cross-sectional study assessed the CC knowledge of 224 adults with T1DM, and the results showed that 54% practiced CC, with a mean knowledge score of 23.01 out of a possible higher score. Factors such as frequency of CC education, insulin pump use, and duration of diabetes significantly influenced CC knowledge scores.
- The study highlights the need for tailored nutrition education programs to improve CC knowledge and management strategies among diabetes patients in Saudi Arabia.